Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hNSC-01 in Huntington's Disease
NCT07451613Phase 2Recruiting
- Start
- Apr 2026
- Primary completion
- Jun 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of hNSC-01 in Huntington's disease (HD). Started Apr 2026; status: recruiting.
02
Drugs
hNSC-01
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT07451613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07451613.